Single dose analgesic efficacy of tapentadol in postsurgical dental pain: The results of a randomized, double-blind, placebo-controlled study

Anesthesia and Analgesia

Volumn 107, Issue 6, 2008, Pages 2048-2055

  Kleinert, Regina ^a   Lange, Claudia ^a   Steup, Achim ^a   Black, Peter ^b   Goldberg, Jutta ^a   Desjardins, Paul ^b  

^a GRÜNENTHAL GMBH   (Germany)

^b Premier Research   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; IBUPROFEN; MORPHINE; MORPHINE SULFATE; PLACEBO; TAPENTADOL; 3-(3-DIMETHYLAMINO-1-ETHYL-2-METHYLPROPYL)PHENOL; MU OPIATE RECEPTOR; PHENOL DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ANALGESIA; ANXIETY; ARTICLE; ASTHENIA; BRADYCARDIA; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEELING ABNORMAL; FEMALE; FISHER EXACT TEST; HOT FLUSH; HUMAN; HYPERHIDROSIS; HYPERTENSION; INCIDENCE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MANDIBLE; MULTICENTER STUDY; MUSCLE WEAKNESS; NAUSEA; OTALGIA; PAIN ASSESSMENT; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE PAIN; POSTSURGICAL DENTAL PAIN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RESPIRATION DEPRESSION; SIDE EFFECT; SINGLE DRUG DOSE; SOMNOLENCE; SORE THROAT; TOOTH EXTRACTION; TOOTH PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE; TREMOR; UPPER ABDOMINAL PAIN; VISUAL ANALOG SCALE; VOMITING; DRUG POTENTIATION;

ADULT; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IBUPROFEN; MALE; MORPHINE; PAIN, POSTOPERATIVE; PHENOLS; RECEPTORS, OPIOID, MU; TOOTHACHE;

EID: 58149308239     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1213/ane.0b013e31818881ca     Document Type: Article

References (30)

1. Averbuch M, Katzper M. Severity of baseline pain and degree of analgesia in the third molar post-extraction dental pain model. Anesth Analg 2003;97:163-7, table of contents
2. Bentley KC, Head TW. The additive analgesic efficacy of acetaminophen, 1000 mg, and codeine, 60 mg, in dental pain. Clin Pharmacol Ther 1987;42:634-40
3. Cooper SA. Single-dose analgesic studies: the upside and downside of assay sensitivity. In: Max M, Portenoy R, Laska E, eds. Advances in pain research and therapy. Vol 18. New York, NY: Raven Press, Ltd., 1991:117-24
4. Desjardins PJ, Norris LH, Cooper SA, Reynolds DC. Analgesic efficacy of intranasal butorphanol (Stadol NS) in the treatment of pain after dental impaction surgery. J Oral Maxillofac Surg 2000;58(10 Suppl 2):19-26
5. Food and Drug Administration. FDA Guideline for the Clinical Evaluation of Analgesic Drugs. DHHS Pub. No. 93-3093. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Food and Drug Administration, 2002
6. Forbes JA, Oral surgery. In: Max M, Portenoy R, Laska E, eds. Advances in pain research and therapy. Vol 18. New York, NY: Raven Press, Ltd., 1991:347-74
7. Fricke JR Jr, Hewitt DJ, Jordan DM, Fisher A, Rosenthal NR. A double-blind placebo-controlled comparison of tramadol/ acetaminophen and tramadol in patients with postoperative dental pain. Pain 2004;109:250 -7
8. Jackson ID, Heidemann BH, Wilson J, Power I, Brown RD. Double-blind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofen trometamol in surgical dentistry. Br J Anaesth 2004;92:675-80
9. Jung YS, Kim DK, Kim MK, Kim HJ, Cha IH, Lee EW. Onset of analgesia and analgesic efficacy of tramadol/acetaminophen and codeine/acetaminophen/ibuprofen in acute postoperative pain: a single-center, single-dose, randomized, activecontrolled, parallel-group study in a dental surgery pain model. Clin Ther 2004;26:1037- 45
10. Kellstein D, Ott D, Jayawardene S, Fricke J. Analgesic efficacy of a single dose of lumiracoxib compared with rofecoxib, celecoxib and placebo in the treatment of post-operative dental pain. Int J Clin Pract 2004;58:244-50
11. Mehlisch DR, Desjardins PJ, Daniels S, Hubbard RC. The analgesic efficacy of intramuscular parecoxib sodium in postoperative dental pain. J Am Dent Assoc 2004;135:1578-90
12. Chang DJ, Bird SR, Bohidar NR, King T. Analgesic efficacy of rofecoxib compared with codeine/acetaminophen using a model of acute dental pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;100:e74-e80
13. Litkowski LJ, Christensen SE, Adamson DN, Van Dyke T, Han SH, Newman KB. Analgesic efficacy and tolerability of oxycodone 5 mg/ibuprofen 400 mg compared with those of oxycodone 5 mg/acetaminophen 325 mg and hydrocodone 7.5 mg/acetaminophen 500 mg in patients with moderate to severe postoperative pain: a randomized, double-blind, placebo-controlled, single-dose, parallel-group study in a dental pain model. Clin Ther 2005;27:418 -29
14. Wermeling DP, Grant GM, Lee A, Alexander N, Rudy AC. Analgesic effects of intranasal butorphanol tartrate administered via a unit-dose device in the dental impaction pain model: a randomized, double-blind, placebo-controlled, parallel-group study. Clin Ther 2005;27:430-40
15. McQuay H, Moore A. Oral ibuprofen and diclofenac in postoperative pain. In: McQuay H, Moore A, eds. An evidence-based resource for pain. Oxford, New York, Tokyo: Oxford University Press; 1998:78-83
16. Brown AK, Christo PJ, Wu CL. Strategies for postoperative pain management. Best Pract Res Clin Anaesthesiol 2004;18:703-17
17. Andersohn F, Suissa S, Garbe E. Use of first- and secondgeneration cyclooxygenase-2-selective nonsteroidal antiinflammatory drugs and risk of acute myocardial infarction. Circulation 2006;113:1950-7
18. Caldwell B, Aldington S, Weatherall M, Shirtcliffe P, Beasley R. Risk of cardiovascular events and celecoxib: a systematic review and meta-analysis. J R Soc Med 2006;99:132-40
19. Fitzgerald GA. Coxibs and cardiovascular disease. N Engl J Med 2004;351:1709-11
20. Tzschentke TM, Christoph T, Kögel B, Schiene K, Hennies H-H, Englberger W, Haurand M, Jahnel U, Cremers TIFH, Friderichs E, De Vry J. (-)-(1R,2R)-3-(3-Dimethylamino-1-ethyl-2-methyl-propyl)- phenol hydrochloride (tapentadol HCl): a novel - opioid receptor agonist/norepinephrine reuptake inhibitor with broad-spectrum analgesic properties. J Pharmacol Exp Ther 2007;323:265-76
21. Tzschentke TM, de Vry J, Terlinden R, Hennies H-H, Lange C, Strassburger W, Haurand M, Kolb J, Schneider J, Buschmann H, Finkam M, Jahnel U, Friedrichs E. Tapentadol HCl. Drugs Future 2006;31:1053-61
22. Lotsch J, Weiss M, Ahne G, Kobal G, Geisslinger G. Pharmacokinetic modeling of M6G formation after oral administration of morphine in healthy volunteers. Anesthesiology 1999;90:1026-38
23. Terlinden R, Ossig J, Fliegert F, Gohler K. Pharmacokinetics, excretion, and metabolism of tapentadol HCl, a novel centrally acting analgesic, in healthy subjects. J Pain 2006;7(suppl 1):S26. Abstract 689
24. Schou S, Nielsen H, Nattestad A, Hillerup S, Ritzau M, Branebjerg PE, Bugge C, Skoglund LA. Analgesic doseresponse relationship of ibuprofen 50, 100, 200, and 400 mg after surgical removal of third molars: a single-dose, randomized, placebo-controlled, and double-blind study of 304 patients. J Clin Pharmacol 1998;38:447-54
25. Laska EM, Siegel C, Sunshine A. Onset and duration: measurement and analysis. In: Max MB, Portenoy RK, Laska EM, eds. The design of analgesic clinical trials. New York, NY: Raven Press; 1991:691-8
26. Maurer W, Hothorn LA, Lehmacher W. Multiple comparisons in drug clinical trials and preclinical assays: a-priori ordered hypotheses. In: Vollmar J, ed. Biometrie in der chemisch-pharmazeutischen Industrie 6, Testprinzipien in klinischen und präklinischen Studien. Stuttgart, Jena, New York: Gustav Fischer Verlag, 1995
27. Lemeshow S, Hosmer DW, Klar J, Lwange SK. Adequacy of sample size in health studies. Chichester, New York, Brisbane, Singapore: John Wiley & Sons, 1990
28. Ridgway D. Analgesics for acute pain: meeting the United States Food and Drug Administration's requirements for proof of efficacy. Clin J Pain 2004;20:123-32
29. Inturrisi CE. Clinical pharmacology of opioids for pain. Clin J Pain 2002;18(4 Suppl):S3-13
30. Reisine T, Pasternak G. Opioid analgesics and antagonists. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilman's: the pharmacologic basis of therapeutics. 9th ed. New York, NY: McGraw-Hill, 1996:528-33